By: Sadie Steffens, 4th year PhD candidate in the Biomedical Sciences Graduate Program
Source: PDPics (Pixabay)
You’d be hard-pressed to find anyone who hasn’t been affected by cancer in some way.
Second only to heart disease as the leading cause of death, many of us have friends or loved ones who have suffered from cancer. News reports with big claims about novel cancer treatments give us hope, and we have a strong desire to eradicate the disease. We want to believe that a cure is imminent, possibly even in our own lifetime.
Although we don’t discuss it much as a society, cancer affects more than our emotions. We are all paying the financial costs of cancer, costs that are escalating so quickly that they will soon be unsustainable. I’m talking about the cost of cancer drugs.
By: Jordan Gaines Lewis, 4th year PhD candidate in the Neuroscience Graduate Program
Gamblers beware. Nadavspi (Wikimedia Commons)
My brief experience in a casino was pretty typical, I’d say.
Flashing lights. The faint smell of booze. Not much chatter among patrons. The sounds of dice rolling, machines buzzing, and coins clanking. The same butts inhabiting the same stools for hours on end. Everything you see on TV or in the movies is fairly accurate, to my untrained eye.
But one thing I didn’t notice in either the movies or real life, likely due in part to the gaudy décor, was the abundance of defibrillators lining the walls.
While nearly as common as water fountains and restrooms in public spaces like schools, malls, and airports, automated external defibrillators (AEDs) have more recently taken up residence in a place that probably needs it most of all: the casino.